StockNews.com lowered shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other brokerages have also recently issued reports on CRBP. Royal Bank of Canada assumed coverage on Corbus Pharmaceuticals in a research report on Monday, May 13th. […]
Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded to Sell at StockNews.com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded at Jefferies Financial Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday morning. Separately, Oppenheimer upped their price objective on shares of Corbus Pharmaceuticals from $20.00 to $51.00 and gave the company an outperform rating in a research note on […]
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its price objective increased by Oppenheimer from $20.00 to $51.00 in a research note published on Monday, Benzinga reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. Separately, StockNews.com started coverage on shares of Corbus Pharmaceuticals in a research report on Friday, January 26th. They […]
Corbus Pharmaceuticals (NASDAQ:CRBP) Earns Hold Rating from Analysts at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated by Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance Corbus Pharmaceuticals stock opened at $5.25 on Friday. Corbus Pharmaceuticals has a 52 week low of $2.11 and a […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 45,500 shares, a drop of 19.8% from the November 15th total of 56,700 shares. Approximately 1.0% of the company’s stock are short sold. Based on an average daily […]
Investment analysts at StockNews.com assumed coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance NASDAQ:CRBP opened at $5.50 on Friday. The stock has a fifty day moving average price of $5.20 […]